An Electrochemical Nucleic Acid Biosensor for Triple-Negative Breast Cancer Biomarker Detection.

Area of Science:

• Biomedical Engineering
• Oncology
• Molecular Diagnostics

Background:

• Triple-negative breast cancer (TNBC) is an aggressive subtype, often diagnosed late.
• Current diagnostic methods for TNBC lack early detection capabilities.
• There is a critical need for early diagnostic tools to improve patient outcomes.

Purpose of the Study:

• To develop and evaluate a novel electrochemical biosensor for early TNBC detection.
• To utilize microRNA-10b (miRNA-10b) as a specific biomarker for TNBC.
• To establish a sensitive and specific diagnostic method for TNBC prior to metastasis.

Main Methods:

• Development and optimization of a novel electrochemical biosensor.
• Detection of microRNA-10b (miRNA-10b) using the developed biosensor.
• Validation of biosensor specificity against non-target microRNAs.
• Testing the biosensor's efficacy on human serum samples.

Main Results:

• The electrochemical biosensor successfully detected microRNA-10b (miRNA-10b).
• Achieved a low detection limit of 10 pM for miRNA-10b.
• Demonstrated high specificity, distinguishing target miRNA from similar non-target sequences.
• Validated the biosensor's performance in human serum samples.

Conclusions:

• The novel electrochemical biosensor is a promising tool for the early diagnosis of triple-negative breast cancer (TNBC).
• The use of miRNA-10b as a biomarker, detected by this biosensor, facilitates early detection.
• This technology has the potential to improve TNBC management and patient prognosis.